Group Medical VIsits for Alcohol Use Disorder

Phase-Based Progress Estimates
Vanderbilt University Medical Center, Nashville, TN
Alcohol Use Disorder+5 More
Shared Medical Visit - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a support group intervention can help improve emotional wellbeing and loneliness for people with multiple chronic diseases. Group Medical VIsits is a treatment for Alcohol Use Disorder that does not involve giving patients a placebo.

Eligible Conditions

  • Alcohol Use Disorder
  • Anxiety
  • Depression
  • Loneliness
  • Utilization, Health Care

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 0,3,6, and 9 months

Month 9
Change in the number of ED visits, Inpatient, Observations
Month 9
Change in Loneliness from Baseline at 0 and at 3, 6 and 9 months.
Month 9
Change in Depression from Baseline (0), and at 3, 6, and 9 months
0,3,6, and 9 months
Change in Active alcohol use disorders (including alcohol abuse or dependence) from Baseline (0), and at 3, 6, and 9 months

Trial Safety

Trial Design

2 Treatment Groups

Standard Care
1 of 2
Group Medical VIsits
1 of 2
Active Control

30 Total Participants · 2 Treatment Groups

Primary Treatment: Group Medical VIsits · No Placebo Group · N/A

Standard CareNoIntervention Group · 1 Intervention: Standard Care · Intervention Types:
Group Medical VIsits
ActiveComparator Group · 1 Intervention: Shared Medical Visit · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 0,3,6, and 9 months
Closest Location: Vanderbilt University Medical Center · Nashville, TN
Photo of vanderbilt university medical center 1Photo of vanderbilt university medical center 2Photo of vanderbilt university medical center 3
2006First Recorded Clinical Trial
0 TrialsResearching Alcohol Use Disorder
1030 CompletedClinical Trials

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
760 Previous Clinical Trials
590,885 Total Patients Enrolled
FRANCIS S BALUCANPrincipal InvestigatorVanderbilt University Medical Center

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have had two or more unplanned admissions in the last 12 months.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.